Literature DB >> 16627034

Agreement between women's and providers' assessment of hormonal contraceptive risk factors.

Solmaz Shotorbani1, Leslie Miller, David K Blough, Jacqueline Gardner.   

Abstract

OBJECTIVE: To measure agreement between women's self-administered risk factor questionnaire and their providers' evaluation of their medical eligibility for hormonal contraceptive use.
METHODS: This was an anonymous cross-sectional study. Participants were women 15-45 years old who completed a 20-item self-administered questionnaire. Women were recruited from six public health family planning clinics in the Seattle Metropolitan area. A matching medical evaluation questionnaire was completed concurrently by each participant's health care provider. Using provider evaluation as the "gold standard" against which we compared self-reported medical history, we calculated participant-provider agreement with point estimates and 95% confidence interval (CI).
RESULTS: Of 399 participant and provider pairs, participant-provider agreement was obtained for 392 participant pairs. The majority of the participants (90.3%) were 15-30 years old and 77.7% had used a hormonal contraceptive method for more than 1 year. The estimated proportion of the overall agreement was 96% (95% CI, 0.92-0.98). Women were more likely to report severe headaches (12.4% vs. 3.3%), possible pregnancy (7.3% vs. 3.5%) and smoking (6.2% vs. 2.1%) than providers, but less likely to report smoking more than 15 cigarettes per day (2.6% vs. 9.2%) and irregular menses (6.5% vs. 9.9%).
CONCLUSION: Overall, a high proportion of the women in this study completed our medical history questionnaire in concordance with their health care providers' same-day medical evaluation. Agreement on critical medical eligibility criteria such as hypertension was well above 90%. For criteria on which there was disagreement, women were more likely to identify contraindications than were their providers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16627034     DOI: 10.1016/j.contraception.2005.12.001

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  16 in total

1.  Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use.

Authors:  Julianne R Lauring; Erik B Lehman; Timothy A Deimling; Richard S Legro; Cynthia H Chuang
Journal:  Am J Obstet Gynecol       Date:  2016-04-05       Impact factor: 8.661

2.  Contraindications to progestin-only oral contraceptive pills among reproductive-aged women.

Authors:  Kari White; Joseph E Potter; Kristine Hopkins; Leticia Fernández; Jon Amastae; Daniel Grossman
Journal:  Contraception       Date:  2012-02-24       Impact factor: 3.375

3.  Contraindications to combined oral contraceptives among over-the-counter compared with prescription users.

Authors:  Daniel Grossman; Kari White; Kristine Hopkins; Jon Amastae; Michele Shedlin; Joseph E Potter
Journal:  Obstet Gynecol       Date:  2011-03       Impact factor: 7.661

4.  Pharmacist prescription of hormonal contraception in Oregon: Baseline knowledge and interest in provision.

Authors:  Maria I Rodriguez; K John McConnell; Jonas Swartz; Alison B Edelman
Journal:  J Am Pharm Assoc (2003)       Date:  2016 Sep-Oct

5.  Bills as Band-Aids: Hopes and Challenges of Expanding Pharmacists' Prescriptive Authority to Include Contraceptives.

Authors:  Kathrine Bendtsen
Journal:  HEC Forum       Date:  2019-12

6.  Perceptions of the safety of oral contraceptives among a predominantly Latina population in Texas.

Authors:  Daniel Grossman; Leticia Fernández; Kristine Hopkins; Jon Amastae; Joseph E Potter
Journal:  Contraception       Date:  2009-10-29       Impact factor: 3.375

7.  Reproductive health preventive screening among clinic vs. over-the-counter oral contraceptive users.

Authors:  Kristine Hopkins; Daniel Grossman; Kari White; Jon Amastae; Joseph E Potter
Journal:  Contraception       Date:  2012-04-20       Impact factor: 3.375

8.  Medical contraindications to estrogen and contraceptive use among women veterans.

Authors:  Colleen P Judge; Xinhua Zhao; Florentina E Sileanu; Maria K Mor; Sonya Borrero
Journal:  Am J Obstet Gynecol       Date:  2017-10-27       Impact factor: 8.661

9.  Interest in over-the-counter access to oral contraceptives among women in the United States.

Authors:  Daniel Grossman; Kate Grindlay; Rick Li; Joseph E Potter; James Trussell; Kelly Blanchard
Journal:  Contraception       Date:  2013-04-23       Impact factor: 3.375

10.  Accuracy of self-screening for contraindications to combined oral contraceptive use.

Authors:  Daniel Grossman; Leticia Fernandez; Kristine Hopkins; Jon Amastae; Sandra G Garcia; Joseph E Potter
Journal:  Obstet Gynecol       Date:  2008-09       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.